It’s been a busy few months for the Society’s journals, from the announcement of our latest Journal Impact Factors (see issue 157, Autumn 2025) to journal representation at international conferences such as ENDO 2025 in San Francisco, USA, in July and the ESA-SRB-ANZOS Annual Scientific Meeting in Perth, Australia, in October. Read on to discover the latest highlights from Society publications.

HIGH QUALITY OBESITY RESEARCH 

As this issue of The Endocrinologist shows, recent therapeutic progress in body weight has led to an exciting new era in obesity research. Here we’ve picked out a few of the latest papers on obesity from Journal of Endocrinology and Journal of Molecular Endocrinology:

•    Osteoprotective effects of lifestyle interventions against obesity-induced bone loss in rats by Imerb et al. 

•    Effects of tryptophan-selective lipidated GLP-1 peptides on the GLP-1 receptor by Lu et al. 

•    Contrasting roles for GLP-1R and GIPR in diet-induced obesity by Gao et al. 

•    Effect of metformin on the endometrial proteome of diet-induced obese mice by Malliou-Becher et al.

DEDICATED SECTION ON GROWTH

Endocrine Connections has launched a new section, ‘Growth, Growth Hormone and Growth Factors’, led by Professor Justin Davies. This section specialises in publishing research on all aspects of growth and growth disorders, including growth regulation and growth factor signalling, aiming to advance understanding and support new diagnostic and therapeutic strategies.

IMMUNE FOCUS IN REPRODUCTION

Reproduction and Fertility presents a flagship special collection, ‘Immune Regulation and Inflammatory Mechanisms in Reproductive Health and Disease’, edited by Dr Erin Greaves, Dr Christiane Pleuger and Dr Erick JR Silva. The collection will explore how immune and inflammatory processes shape male and female reproduction, with implications for infertility, pregnancy loss and therapeutic interventions. To propose an article for the collection, contact [email protected].

WELCOMING A NEW EDITOR-IN-CHIEF

Endocrine-Related Cancer welcomes Professor Karel Pacak as Editor-in-Chief from January 2026. A globally renowned expert in neuroendocrine tumours, Professor Pacak brings a wealth of experience and is recognised as the 94th Most Influential NIH Scientist in Medicine. Dr Matthew Ringel will step down, leaving a legacy of strong leadership in cancer biology research.